Parkinson’s Disease Costs Projected to Reach $112 Billion by 2045
According to an economic burden analysis commissioned by the Michael J. Fox Foundation for Parkinson’s Research (MJFF), the total economic impact of Parkinson’s disease in the United States is projected to reach $112 billion by 2045, representing a substantial increase over current estimates. The analysis evaluated direct medical, indirect, and non-medical costs and reflects a […]
“Profound Autism” Under Consideration as New Diagnosis
Autism has emerged as one of the most intensely debated public health issues over the past three decades, but especially during the past year. U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. has vowed to launch a sweeping research initiative aimed at identifying underlying causes of autism—a move applauded by some advocates […]
CDC Will Offer Contract to Investigate Link Between Autism and Vaccination
The U.S. Centers for Disease Control and Prevention (CDC) intends to award a contract to Rensselaer Polytechnic Institute (RPI) to investigate links between autism prevalence and vaccination according to a notice on the federal website. The notice, posted in September 2025, indicated that the CDC planned to issue the fixed-price contract to the New York […]
Cancer Treatments Using mRNA Technology Targeted as COVID Shots Sales Decline
BioNTech SE and Moderna, Inc., two leading pharmaceutical companies that developed the mRNA COVID-19 biological, are facing new financial and regulatory challenges as demand for COVID booster shots continues to fall and U.S. health policy changes reshape the vaccine market.1 Moderna cut its 2025 sales forecast to between $1.5 billion and $2.2 billion, down as […]
Novel “Inverse Vaccines” Could Soon Target Autoimmune Diseases
A novel class of therapies that are labeled vaccines—known as ‘inverse vaccines’—are designed to treat autoimmune disorders and could be made available in just a few years. In January, Swiss biotech company Anokion—which focuses on improving treatments and health outcomes for individuals suffering with autoimmune disorders—announced promising early human trials of inverse “vaccines” targeting celiac […]
Autism Epidemic ‘Unprecedented in Human History,’ Now Reaches 1 in 31 Kids in America
On Apr. 15, 2025, the U.S. Centers for Disease Control and Prevention (CDC) published an analysis in its epidemiological digest Morbidity and Mortality Weekly Report (MMWR) which found the prevalence of autism spectrum disorder (ASD) among children eight years old in the United States to be 1 in 31 (3.2 percent).1 2 3 4 5 […]